Skip to main content
. 2010 Mar;24(3):183–188. doi: 10.1155/2010/349076

TABLE 1.

Baseline clinical, biochemical and arterial blood gas profiles of patients with hepatopulmonary syndrome taking garlic (group 1) or placebo (group 2)

Parameter Group 1 (n=21) Group 2 (n=20) P
Age, years 37.6±13.06 40.0±14.11 0.40
Male:female, n 17:4 18:2
Etiology, n
  Alcoholic liver disease 7 9
  Chronic hepatitis B infection 5 8
  Chronic hepatitis C infection 2
  Autoimmune 2 1
  Wilson’s disease 1
  Cryptogenic 4 2
Disease duration, years 14.23±5.04 14.05±6.56 0.92
Orthodeoxia, n 14 12 0.91*
Cyanosis, n 17 15 0.93*
Clubbing, n 19 18 0.63*
Spider angioma, n 3 5 0.64*
Alanine aminotransferase, U/mL 56.27±25.47 63.63±41.36 0.60
SO2, mmHg 93.86±1.15 93.7±1.08 0.66
PaO2, mmHg 66.62±5.59 64.05±4.68 0.12
P(A-a)O2, mmHg 29.77±6.10 32.61±4.88 0.11
MELD score 14.58±5.28 15.75±6.94 0.59
Child-Pugh score
  Child’s class A 3 4 0.94*
  Child’s class B 7 3 0.32*
  Child’s class C 11 13 0.62*

Data presented as mean ± SD unless indicated otherwise.

*

Value calculated by χ2 test. MELD Model for End-Stage Liver Disease; P(A-a)O2 Alveolar-arterial oxygen gradient; PaO2 Partial pressure of oxygen in arterial blood; SO2 Oxygen saturation detected by pulse oximetry